APMD 8-K: Restatement

Apnimed's Audit Committee concluded that its previously

Filed with the SEC on · accession 0001193125-26-460864

APMD filed a 8-K (current report) with the SEC on Nov 13, 2026. Apnimed's Audit Committee concluded that its previously issued Q2 2026 financial statements should no longer be relied upon due to a misclassification of an $85.4 million gain on the disposition of its SASS equity method investment as continuing operations rather than discontinued operations. The stock moved +1.7% by the first close after the filing.

Summary of the filing

Apnimed's Audit Committee concluded that its previously issued Q2 2026 financial statements should no longer be relied upon due to a misclassification of an $85.4 million gain on the disposition of its SASS equity method investment as continuing operations rather than discontinued operations. The company plans to restate the affected periods via a Form 10-Q/A.

Key details

Gain on disposition of equity method investment in SASS$85.4M
RegistrantApnimed, Inc.
Equity method investment disposed ofShionogi-Apnimed Sleep Science, LLC (SASS)
Buyer of sass interestShionogi & Co., Ltd.
Independent registered public accounting firmDeloitte & Touche LLP

How APMD stock reacted

Close before

$16.63

Nov 12, 2026

First close after

+1.74%

$16.92

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for APMD, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for APMD?

Click here

Frequently asked questions

What did APMD file with the SEC on Nov 13, 2026?

APMD filed a 8-K (Restatement). Apnimed's Audit Committee concluded that its previously issued Q2 2026 financial statements should no longer be relied upon due to a misclassification of an $85.4 million gain on the disposition of its SASS equity method investment as continuing operations rather than discontinued operations. The company plans to restate the affected periods via a Form 10-Q/A.

What does a restatement mean for APMD stock?

The stock often falls sharply. In a Chapter 11 reorganization existing shares are frequently cancelled or heavily diluted; in Chapter 7 the company is liquidated and shareholders are paid last, usually nothing.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did APMD stock react to this filing?

APMD closed at $16.63 before the filing and $16.92 on Nov 13, 2026 (+1.74%).

Other APMD SEC filings

Get alerts when APMD files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days